Details for 2017800090
Up to date per 01.04.2026
Actions
Details for 2017800090
Deleted
European Patent
27.03.2019 A
08.11.2023 B1
17.05.2016
US
201662337645 P
25.08.2016
US
201662379402 P
19.09.2016
US
201662396587 P
11.11.2016
US
201662420836 P
23.11.2016
US
201662425717 P
C12Q 1/68 20180101AFI20200121BHEP
Owner
Genecentric Therapeutics, Inc.79 TW Alexander Drive 4401 Research Commons, Suite 105 Research Triangle Park, NC 27709US
The University Of North Carolina At Chapel Hill100 Europa Drive Suite 430 Chapel Hill, North Carolina 27517US
Representative
No representatives present
Inventor
FARUKI, Hawazinc/o GeneCentric Therapeutics Inc. 79 TW Alexander Drive 4401 Research Commons, Suite 105 Research Triangle Park North Carolina 27709US
LAI-GOLDMAN, Mylac/o GeneCentric Diagnostics Inc. 79 TW Alexander Drive 4401 Research Commons, Suite 105 Research Triangle Park, NC 27709US
MAYHEW, Gregc/o GeneCentric Therapeutics Inc. 79 TW Alexander Drive 4401 Research Commons, Suite 105 Research Triangle Park North Carolina 27709US
SERODY, Jonathanc/o GeneCentric Therapeutics Inc. 79 TW Alexander Drive 4401 Research Commons, Suite 105 Research Triangle Park North Carolina 27709US
PEROU, Charlesc/o GeneCentric Therapeutics Inc. 79 TW Alexander Drive 4401 Research Commons, Suite 105 Research Triangle Park North Carolina 27709US
HAYES, David Neilc/o GeneCentric Therapeutics Inc. 79 TW Alexander Drive 4401 Research Commons, Suite 105 Research Triangle Park North Carolina 27709US